le Roux DM, Zar HJ. Community-acquired pneumonia in children – a changing spectrum of disease. Pediatr Radiol. 2017;47(11):1392–8.
Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.
Uwemedimo OT, Lewis TP, Essien EA, Chan GJ, Nsona H, Kruk ME, Leslie HH. Distribution and determinants of pneumonia diagnosis using Integrated Management of Childhood Illness guidelines: a nationally representative study in Malawi. BMJ Glob Health. 2018;3(2):e000506.
Kanyuka M, Ndawala J, Mleme T, Chisesa L, Makwemba M, Amouzou A, Borghi J, Daire J, Ferrabee R, Hazel E, et al. Malawi and Millennium Development goal 4: a countdown to 2015 country case study. Lancet Glob Health. 2016;4(3):e201–214.
Fancourt N, Deloria Knoll M, Barger-Kamate B, de Campo J, de Campo M, Diallo M, Ebruke BE, Feikin DR, Gleeson F, Gong W, et al. Standardized interpretation of chest radiographs in cases of Pediatric Pneumonia from the PERCH Study. Clin Infect Dis. 2017;64(suppl3):S253–61.
Roca A, Sigauque B, Quinto L, Morais L, Berenguera A, Corachan M, Ribo JL, Naniche D, Bassat Q, Sacoor C, et al. Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. Vaccine. 2010;28(30):4851–7.
Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine. 2008;26(38):4947–54.
Iliya J, Shatima DR, Tagbo BN, Ayede AI, Fagbohun AO, Rasaq A, Nalban S, Elon IW, Mohammed-Nafiu R, Ahmed P, et al. Pneumonia hospitalizations and mortality in children 3–24-month-old in Nigeria from 2013 to 2020: impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10). Hum Vaccin Immunother. 2023;19(1):2162289.
Hortal M, Estevan M, Meny M, Iraola I, Laurani H. Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. PLoS ONE. 2014;9(6):e98567.
Erdman LK, D’Acremont V, Hayford K, Rajwans N, Kilowoko M, Kyungu E, Hongoa P, Alamo L, Streiner DL, Genton B, et al. Biomarkers of host response predict primary end-point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: a prospective cohort study. PLoS ONE. 2015;10(9):e0137592.
Enwere G, Cheung YB, Zaman SM, Akano A, Oluwalana C, Brown O, Vaughan A, Adegbola R, Greenwood B, Cutts F. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007;12(11):1377–85.
Awasthi S, Kohli N, Agarwal M, Pandey CM, Rastogi T, Pandey AK, Roy C, Mishra K, Verma N, Kumar CB, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: a prospective multi-site hospital-based test-negative study in Northern India. PLoS ONE. 2022;17(12):e0276911.
Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M, Greenberg D, Lagos R, Lucero M, Madhi SA, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353–9.
Office NS. Malawi Demographic and Health Survey 2015-16. In.; 2015.
Mvula H, Heinsbroek E, Chihana M, Crampin AC, Kabuluzi S, Chirwa G, Mwansambo C, Costello A, Cunliffe NA, Heyderman RS, et al. Predictors of Uptake and timeliness of newly introduced pneumococcal and Rotavirus vaccines, and of Measles Vaccine in Rural Malawi: a Population Cohort Study. PLoS ONE. 2016;11(5):e0154997.
Heinsbroek E, Tafatatha T, Phiri A, Swarthout TD, Alaerts M, Crampin AC, Chisambo C, Mwiba O, Read JM, French N. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine. 2018;36(48):7369–76.
Swarthout TD, Fronterre C, Lourenco J, Obolski U, Gori A, Bar-Zeev N, Everett D, Kamng’ona AW, Mwalukomo TS, Mataya AA, et al. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi. Nat Commun. 2020;11(1):2222.
Bar-Zeev N, Swarthout TD, Everett DB, Alaerts M, Msefula J, Brown C, Bilima S, Mallewa J, King C, von Gottberg A, et al. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies. Lancet Glob Health. 2021;9(7):e989–98.
Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187(9):1424–32.
Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Ruckinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51(6):692–9.
Deloria Knoll M, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Madhi SA, Murdoch DR, et al. Introduction to the site-specific etiologic results from the Pneumonia Etiology Research for Child Health (PERCH) study. Pediatr Infect Dis J. 2021;40(9S):S1–6.
Moore DP, Baillie VL, Mudau A, Wadula J, Adams T, Mangera S, Verwey C, Sipambo N, Liberty A, Prosperi C, et al. The etiology of Pneumonia in HIV-1-infected South African children in the era of antiretroviral treatment: findings from the Pneumonia Etiology Research for Child Health (PERCH) study. Pediatr Infect Dis J. 2021;40(9S):S69–78.
Chikhaoui A, Nzoyikorera N, Diawara I, Jouhadi Z, Zerouali K. Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination. Pan Afr Med J. 2022;41:2.
Kirolos A, Swarthout TD, Mataya AA, Bonomali F, Brown C, Msefula J, Bar-Zeev N, Iroh Tam PY, Alaerts M, Bilima S, et al. Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi. BMC Infect Dis. 2023;23(1):56.
Raboba JL, Rahajamanana VL, Andriatahirintsoa EPR, Razafindrakoto AC, Andrianarivelo AM, Nimpa Mengouo M, Vuo Masembe Y, Weldegebriel GG, de Gouveia L, Mwenda JM, et al. Decline in vaccine-type Streptococcus pneumoniae serotypes following pneumococcal conjugate vaccine introduction in Madagascar. J Infect Dis. 2021;224(12 Suppl 2):S285–92.
Silaba M, Ooko M, Bottomley C, Sande J, Benamore R, Park K, Ignas J, Maitland K, Mturi N, Makumi A, et al. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis. Lancet Glob Health. 2019;7(3):e337–46.
Isturiz R, Grant L, Gray S, Alexander-Parrish R, Jiang Q, Jodar L, Peyrani P, Ford KD, Pride MW, Self WH, et al. Expanded analysis of 20 pneumococcal serotypes Associated with Radiographically confirmed community-acquired Pneumonia in hospitalized US adults. Clin Infect Dis. 2021;73(7):1216–22.
Hansen K, Runow E, Torisson G, Theilacker C, Palmborg A, Pan K, Jiang Q, Southern J, Beavon R, Gessner BD, et al. Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study. Front Public Health. 2023;11:1086648.
Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, Baskaran V, Edwards-Pritchard RC, Sheppard C, Eletu SD, et al. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax. 2020;75(1):38–49.
Elfving K, Stromberg LG, Geravandi S, Andersson M, Bachelard M, Msellem M, Shakely D, Trollfors B, Norden R, Martensson A, et al. Pneumococcal concentration and serotype distribution in preschool children with radiologically confirmed pneumonia compared to healthy controls prior to introduction of pneumococcal vaccination in Zanzibar: an observational study. BMC Infect Dis. 2022;22(1):925.
Add Comment